Caplin Point Laboratories Q2 Results

  • BSE: 524742
  • NSE: CAPLIPOINT
  • ISIN: INE475E01026
  • Sector: Biotechnology & Drugs
BSE
1,969.554.60 (0.23%)
Volume7.99 K
Updated: Mon 25 Nov, 2024 | 15:29:00
NSE
1,97713.25 (0.67%)
Volume65.86 K
Updated: Mon 25 Nov, 2024 | 15:29:51
Today: 1,945.00
2,005.00
52-Wk: 1,179.95
2,175.00

Q2 Results Highlights

  • Total Income
    ₹483.10 Cr.
    (5.26%)
  • Operating Profit
    ₹148.00 Cr.
    (8.94%)
  • Profit After Tax
    ₹130.80 Cr.
    (5.50%)
  • Operating Margin
    30.64%
    (-0.01%)
Note: Comparison is on YoY basis

Quarterly - Caplin Point Laboratories Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 483.10395.32-%410.06-%
Selling/ General/ Admin Expenses Total 44.2935.07-%35.08-%
Depreciation/ Amortization 16.7611.38-%11.76-%
Other Operating Expenses Total 85.2355.12-%73.48-%
Total Operating Expense 335.10280.17-%284.42-%
Operating Income 148.00115.15-%125.64-%
Net Income Before Taxes 168.46126.99-%146.00-%
Net Income 130.80103.43-%114.87-%
Diluted Normalized EPS 17.1213.55-%15.06-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts